Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Petzelbauer

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|November 11, 2020
Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 InhibitionPeter Petzelbauer
Journal of Cutaneous Pathology|February 4, 2009
Janeway lesions with inconspicuous histological featuresRobert Loewe, Klaus B Gattringer, Peter Petzelbauer
Journal of Molecular Medicine (Berlin, Germany)|May 31, 2006
Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarctionKai Zacharowski, Paula Zacharowski, Sonja Reingruber, et al.
The Journal of Investigative Dermatology|September 21, 2007
A previously unknown dermal blood vessel phenotype in skin inflammationMarion Gröger, Heide Niederleithner, Dontscho Kerjaschki, et al.
International Journal of Experimental Pathology|March 31, 2011
Embryonic stem cell factors undifferentiated transcription factor-1 (UFT-1) and reduced expression protein-1 (REX-1) are widely expressed in human skin and may be involved in cutaneous differentiation but not in stem cell fate determinationChristina M Reinisch, Michael Mildner, Peter Petzelbauer, et al.
FEMS Immunology and Medical Microbiology|February 19, 2003
Anti-TNF antibody treatment reduces mortality in experimental dengue virus infectionAlena Atrasheuskaya, Peter Petzelbauer, Terry M Fredeking, et al.
Biochemical and Biophysical Research Communications|February 24, 2006
Regulation of matrilysin expression in endothelium by fibroblast growth factor-2Wolfgang Holnthoner, Marc Kerenyi, Marion Gröger, et al.
International Journal of Mass Spectrometry|June 23, 2012
High-throughput flow injection analysis of labeled peptides in cellular samples - ICP-MS analysis versus fluorescence based detectionDaniela Kretschy, Marion Gröger, Daniela Zinkl, et al.
The Journal of Investigative Dermatology|September 18, 2004
BRAF kinase gene V599E mutation in growing melanocytic lesionsRobert Loewe, Harald Kittler, Gottfried Fischer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trialJonas Hallén, Peter Petzelbauer, Jürg Schwitter, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|November 11, 2020
Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 InhibitionPeter Petzelbauer
Journal of Cutaneous Pathology|February 4, 2009
Janeway lesions with inconspicuous histological featuresRobert Loewe, Klaus B Gattringer, Peter Petzelbauer
Journal of Molecular Medicine (Berlin, Germany)|May 31, 2006
Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarctionKai Zacharowski, Paula Zacharowski, Sonja Reingruber, et al.
The Journal of Investigative Dermatology|September 21, 2007
A previously unknown dermal blood vessel phenotype in skin inflammationMarion Gröger, Heide Niederleithner, Dontscho Kerjaschki, et al.
International Journal of Experimental Pathology|March 31, 2011
Embryonic stem cell factors undifferentiated transcription factor-1 (UFT-1) and reduced expression protein-1 (REX-1) are widely expressed in human skin and may be involved in cutaneous differentiation but not in stem cell fate determinationChristina M Reinisch, Michael Mildner, Peter Petzelbauer, et al.
FEMS Immunology and Medical Microbiology|February 19, 2003
Anti-TNF antibody treatment reduces mortality in experimental dengue virus infectionAlena Atrasheuskaya, Peter Petzelbauer, Terry M Fredeking, et al.
Biochemical and Biophysical Research Communications|February 24, 2006
Regulation of matrilysin expression in endothelium by fibroblast growth factor-2Wolfgang Holnthoner, Marc Kerenyi, Marion Gröger, et al.
International Journal of Mass Spectrometry|June 23, 2012
High-throughput flow injection analysis of labeled peptides in cellular samples - ICP-MS analysis versus fluorescence based detectionDaniela Kretschy, Marion Gröger, Daniela Zinkl, et al.
The Journal of Investigative Dermatology|September 18, 2004
BRAF kinase gene V599E mutation in growing melanocytic lesionsRobert Loewe, Harald Kittler, Gottfried Fischer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trialJonas Hallén, Peter Petzelbauer, Jürg Schwitter, et al.
Pageof 10